Abstract

摘要:

<正>肝细胞癌 (HCC) 为全球性疾病,其发病率在全球范围内各不相同,在北美 (4. 9/100 000) 和欧洲 (5. 8/100 000) 最低,在东亚地区 (35. 5/100 000) 最高,主要是因为东亚地区感染慢性乙型肝炎患者较多[1]。其致病因素包括慢性乙型肝炎或丙型肝炎、肝硬化、重度饮酒、遗传性血色素沉着症、黄曲霉毒素暴露、种族/基因组成、自身免疫性肝炎、非酒精性脂肪肝等[2-3]。其中有研究[4]发现,2型糖尿病会增加HCC的发病率,且Wang等[5]前瞻性研究表明与非糖尿病人群相比,糖尿病患者中包含

Details

Title
他汀类药物对2型糖尿病患者发生肝细胞癌风险的影响
Author
施凤; 雷宇鹏
Pages
161-163
Section
Brief reports
Publication year
2019
Publication date
2019
Publisher
Journal of Clinical Hepatology
ISSN
10015256
e-ISSN
20973497
Source type
Scholarly Journal
Language of publication
Chinese
DOI
https://doi.org/10.3969/j.issn.1001-5256.2019.01.031
ProQuest document ID
3240455744
Copyright
© 2019. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.